APA (7th ed.) Citation

Alhalabi, O., Dao Trong, H. P., Kaes, M., Jakobs, M., Keßler, T., Oehler, H., . . . Jungk, C. (2024). Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk-benefit analysis. Journal of neuro-oncology, 167(2), . https://doi.org/10.1007/s11060-024-04595-5

Chicago Style (17th ed.) Citation

Alhalabi, Obada, et al. "Repeat Surgery of Recurrent Glioma for Molecularly Informed Treatment in the Age of Precision Oncology: A Risk-benefit Analysis." Journal of Neuro-oncology 167, no. 2 (2024). https://doi.org/10.1007/s11060-024-04595-5.

MLA (9th ed.) Citation

Alhalabi, Obada, et al. "Repeat Surgery of Recurrent Glioma for Molecularly Informed Treatment in the Age of Precision Oncology: A Risk-benefit Analysis." Journal of Neuro-oncology, vol. 167, no. 2, 2024, https://doi.org/10.1007/s11060-024-04595-5.